Global languages
2022-04-25
Non-regulatory

Save the date for CellaVision Capital Markets Day on June 16, 2022

CellaVision will host a Capital Markets Day on June 16, 2022. During the day, executive management will present the company’s updated strategic direction, which aims to develop and broaden the company’s operations over the next five years. The event is planned to be held at CellaVision head quarter in Lund. Invitation will be sent out closer to the event.

Contact

Adele Horn
Corporate Communications & Investor Relations
Direct: +46 (0) 464 602 604
Mobile: +46 (0) 722 065 088

About Us

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in sample preparation, image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the company´s 17 local market support organizations covering more than 40 countries. In 2021, sales were SEK 566 million and the company's growth target is 15% per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com

Attachments

Save the date for CellaVision Capital Markets Day on June 16, 2022

Share